期刊文献+

2012年至2021年甘肃省医疗机构降压药利用研究

Research on the Utilization of Antihypertensive Drugs of Medical Institutions in Gansu Province from 2012 to 2021
下载PDF
导出
摘要 目的为优化降压药的用药模式提供参考。方法收集2012年至2021年甘肃省公共资源交易中心药品集中招标采购平台中的降压药相关数据,以限定日剂量(DDD)、用药频度(DDDs)、每千人每天用药消耗量(DID)、限定日费用(DDC)、使用金额排序/药品DID排序(B/A)和复合年均增长率(CAGR)描述甘肃省降压药的利用模式。结果共覆盖省内一级医疗机构1356家,二级238家,三级68家。2012年至2019年甘肃省医疗机构降压药的DID和DDC均逐年增加,并在2019年达峰值,2019年至2021年均逐年下降;累积DID占比最高的是肾素-血管紧张素系统(RAS)类降压药(39%),其次是钙离子通道阻断剂(31%)。2012年至2021年,各级医疗机构降压药的DID均总体呈上升趋势,其中一级医疗机构降压药的DID占比最高但总体呈下降趋势,二级、三级医疗机构DID占比总体呈上升趋势。甘肃省2021年DID累积占比前90%的降压药共9种,其中,缬沙坦DID占比最高(29.34%);RAS类降压药品种最多(6种);B/A为0.8~1.2的降压药有3种,分别为依那普利、替米沙坦和非洛地平。结论2012年至2021年甘肃省各级医疗机构降压药的用药结构和DDC基本合理,但消耗量未明显呈现向基层医疗机构下沉的趋势。 Objective To provide a reference for optimizing the utilization mode of antihypertensive drugs.Methods Relevant data of antihypertensive drugs in the centralized drug bidding and procurement platform of Gansu provincial public resource trading center from 2012 to 2021 were collected.The utilization mode of antihypertensive drugs in Gansu province was described by defined daily dose(DDD),defined daily doses(DDDs),daily consumption dose per thousand population(DID),defined daily cost(DDC),consumption amount ranking/drug DID ranking(B/A)and compound annual growth rate(CAGR).Results There were a total of 1356 primary medical institutions,238 secondary medical institutions and 68 tertiary medical institutions in the province involved.The DID and DDC of antihypertensive drugs of medical institutions in Gansu province increased year by year from 2012 to 2019,reaching a peak in 2019 and decreasing year by year from 2019 to 2021.The cumulative DID proportion of renin-angiotensin system(RAS)antihypertensive drugs was the highest(39%),followed by calcium channel blockers(31%).The DID of antihypertensive drugs in medical institutions at all levels showed an overall upward trend from 2012 to 2021,the DID proportion in primary hospitals was the highest but showed an overall downward trend,and that in secondary and tertiary medical institutions showed an overall upward trend.There were nine antihypertensive drugs with the top 90%cumulative DID proportion in Gansu province in 2021,among which valsartan had the highest DID proportion(29.34%).RAS antihypertensive drugs had the most varieties(six types).There were three types of antihypertensive drugs with a B/A in the range of 0.8 to 1.2,namely enalapril,telmisartan and felodipine.Conclusion The medication structure and DDC of antihypertensive drugs of medical institutions at all levels in Gansu province from 2012 to 2021 were basically rational,but the consumption of antihypertensive drugs dose not trend to the grass-roots medical institutions.
作者 冯虎 曹文萱 马永恒 赵德芳 胡晓斌 FENG Hu;CAO Wenxuan;MA Yongheng;ZHAO Defang;HU Xiaobin(Institute of Epidemiology and Health Statistics,School of Public Health,Lanzhou University,Lanzhou,Gansu,China 730000;Gansu Provincial Public Resources Trading Bureau Drug Procurement Centre,Lanzhou,Gansu,China 730000)
出处 《中国药业》 CAS 2023年第20期34-38,共5页 China Pharmaceuticals
基金 兰州大学服务甘肃省经济社会发展专项研究项目[纵20190488] 甘肃省医疗保障局医疗保险省级统筹研究项目[(22)0907]。
关键词 降压药 甘肃省 医疗机构 药物利用 集中采购 antihypertensive drug Gansu province medical institution drug utilization centralized procurement
  • 相关文献

参考文献9

二级参考文献113

  • 1中国居民营养与健康现状[J].中国心血管病研究,2004,2(12):919-922. 被引量:496
  • 2吴佩芬.我院2003~2004年口服降压药物应用分析[J].首都医药,2005,12(18):21-22. 被引量:1
  • 3Berend K, Levi M. Is it time to celebrate a century of blood pressure management? [J]. Nephrol Dial Transplant, 2008, 23 ( 8 ) : 2558-2562.
  • 4Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data[J].Lancet, 2005, 365 (9455) :217-223.
  • 5Kearney PM, Whelton M, Reynolds K, et al. Worldwide prevalence of hypertension: a systematic review[J]. J Hypertens, 2004, 22(1):21-24.
  • 6Muntner P, He J, Cutler JA, et al. Trends in blood pressure among children and adolescents[J].JAMA,2004,291(17):2107-2113.
  • 7Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004[J]. Hypertension,2008,52(5) :818-827.
  • 8Falasehetti E, Chaudhury M, Mindell J, et al. Continued improvement in hypertension management in England: results from the Health Survey for England 2006[J]. Hypertension, 2009,53 (3) :480-486.
  • 9Damasceno A, Azevedo A, Silva-Matos C, et al. Hypertension prevalence, awareness, treatment, and control in mozambique: urban/rural gap during epidemiological transition[J]. Hypertension,2009,54(1) :77-83.
  • 10Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the united states[J]. Circulation, 2005,112 ( 11 ) : 1651-1662.

共引文献4150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部